Search results
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 5 minutes agoIn contrast, Moderna has more than 40 candidates in the pipeline, and as mentioned above, expects to launch several...path to recovery -- and has a key...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 19 hours agovaccine worldwide, citing a decline in demand for the product. Though AstraZeneca’s vaccine was...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 17 hours agoStay tuned for more earnings and pipeline updates. Want the latest recommendations from Zacks...
Moderna Announces Update on Investigational RSV Vaccine
Digital Journal· 7 days agoView the original press release on accesswire.com ACCESSWIRE News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive ...
Is This a Setback for Moderna?
The Motley Fool via AOL· 3 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoThe Stock Advisor service has more than quadrupled the return... Fool has positions in and...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 7 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
The Motley Fool via AOL· 3 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock ...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 2 days agoThe Stock Advisor service has more than quadrupled the return...The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 7 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
